Compare SGMT & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGMT | CURI |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Movies/Entertainment |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.7M | 257.8M |
| IPO Year | 2023 | N/A |
| Metric | SGMT | CURI |
|---|---|---|
| Price | $5.90 | $3.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $29.71 | $6.00 |
| AVG Volume (30 Days) | 622.5K | ★ 653.8K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 8.36% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $66,595,000.00 |
| Revenue This Year | N/A | $42.19 |
| Revenue Next Year | N/A | $7.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 28.62 |
| 52 Week Low | $1.73 | $1.48 |
| 52 Week High | $11.41 | $7.15 |
| Indicator | SGMT | CURI |
|---|---|---|
| Relative Strength Index (RSI) | 37.38 | 36.48 |
| Support Level | $5.92 | $3.79 |
| Resistance Level | $6.33 | $4.00 |
| Average True Range (ATR) | 0.35 | 0.23 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 11.16 | 3.28 |
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.